Cancer is the most common comorbidity in septic patients with nearly 93,000 cases annually. Importantly, cancer is also the comorbidity associated with the highest risk of death in patients with sepsis. We have created a murine model that replicates the increased mortality seen in septic patients with cancer compared to previously healthy patients who develop sepsis. The first goal of this proposal is to understand possible mechanisms through which pre-existing cancer increases mortality when a host develops sepsis. Based upon preliminary data, both the immune system and gut integrity appear to be involved, so each of these will be examined in detail. Experiments will be performed in multiple models of sepsis with multiple tumor lines to determine whether results are generalizable or specific to either type of sepsis or type of cancer. Additionally, there is extensive data from multiple investigative groups that apoptosis prevention in either lymphocytes or the gut epithelium improves survival in previously health rodents with sepsis. However, when this strategy is used in septic mice with cancer, the precise opposite is found with apoptosis prevention either markedly increasing mortality (lymphocytes) or losing its efficacy (intestine). The proposal seeks to understand why a beneficial therapy that has widespread acceptance as a possible treatment approach for patients turns deadly if sepsis occurs in the setting of cancer. Since efforts are currently being made to translate apoptosis prevention into treatment that can be used at the bedside for septic patients, this proposal could potentially change entry criteria and/or prevent inadvertent mortality in patients undergoing clinical trials of apoptosis prevention in sepsis. Thus, the proposal seeks to understand a subpopulation within sepsis that may require a different therapeutic approach than a """"""""typical"""""""" septic host, and this may have significant implications in a disease that is both very common and highly lethal.

Public Health Relevance

Cancer is the most common comorbidity in septic patients with nearly 93,000 cases annually, and cancer is also the comorbidity associated with the highest risk of death in patients with sepsis. Although apoptosis prevention improves survival in previously health rodents with sepsis, apoptosis prevention markedly increases mortality in septic mice with cancer. Understanding a) why mortality is higher in septic hosts with cancer compared to previously healthy septic hosts and b) why a beneficial therapeutic approach turns deadly if sepsis occurs in the setting of cancer may therefore have significant therapeutic implications in a disease that is both very common and highly lethal.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM104323-01
Application #
8425493
Study Section
Special Emphasis Panel (ZRG1-SBIB-J (02))
Program Officer
Dunsmore, Sarah
Project Start
2013-06-01
Project End
2017-03-31
Budget Start
2013-06-01
Budget End
2014-03-31
Support Year
1
Fiscal Year
2013
Total Cost
$296,400
Indirect Cost
$106,400
Name
Emory University
Department
Surgery
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Chen, Ching-Wen; Mittal, Rohit; Klingensmith, Nathan J et al. (2017) Cutting Edge: 2B4-Mediated Coinhibition of CD4+ T Cells Underlies Mortality in Experimental Sepsis. J Immunol 199:1961-1966
Klingensmith, Nathan J; Chen, Ching-Wen; Liang, Zhe et al. (2017) Honokiol Increases CD4+ T Cell Activation and Decreases TNF but Fails to Improve Survival Following Sepsis. Shock :
Meng, Mei; Klingensmith, Nathan J; Coopersmith, Craig M (2017) New insights into the gut as the driver of critical illness and organ failure. Curr Opin Crit Care 23:143-148
Lyons, John D; Klingensmith, Nathan J; Otani, Shunsuke et al. (2017) Sepsis reveals compartment-specific responses in intestinal proliferation and apoptosis in transgenic mice whose enterocytes re-enter the cell cycle. FASEB J 31:5507-5519
Lyons, John D; Coopersmith, Craig M (2017) Pathophysiology of the Gut and the Microbiome in the Host Response. Pediatr Crit Care Med 18:S46-S49
Lorentz, C Adam; Liang, Zhe; Meng, Mei et al. (2017) Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis. Mol Med 23:
Fay, Katherine T; Ford, Mandy L; Coopersmith, Craig M (2017) The intestinal microenvironment in sepsis. Biochim Biophys Acta 1863:2574-2583
Ramonell, Kimberly M; Zhang, Wenxiao; Hadley, Annette et al. (2017) CXCR4 blockade decreases CD4+ T cell exhaustion and improves survival in a murine model of polymicrobial sepsis. PLoS One 12:e0188882
Klingensmith, Nathan J; Yoseph, Benyam P; Liang, Zhe et al. (2017) Epidermal Growth Factor Improves Intestinal Integrity and Survival in Murine Sepsis Following Chronic Alcohol Ingestion. Shock 47:184-192
Yoseph, Benyam P; Klingensmith, Nathan J; Liang, Zhe et al. (2016) Mechanisms of Intestinal Barrier Dysfunction in Sepsis. Shock 46:52-9

Showing the most recent 10 out of 29 publications